Literature DB >> 24754871

Synthetic polyglutamylation of dual-functional MTX ligands for enhanced combined cytotoxicity of poly(I:C) nanoplexes.

Ulrich Lächelt1, Valentin Wittmann, Katharina Müller, Daniel Edinger, Petra Kos, Miriam Höhn, Ernst Wagner.   

Abstract

The antifolate drug methotrexate (MTX) can serve as a dual-functional ligand in antitumoral drug delivery, inducing both a folate receptor mediated cellular uptake and an intracellular cytotoxic action. Bioactivity of MTX however changes by conjugation; the activity can be affected by the hampered intracellular conversion to more potent poly-γ-glutamyl derivatives. Therefore, in a cancer combination therapy approach for the codelivery of cytotoxic dsRNA polyinosinic-polycytidylic acid poly(I:C), a set of molecularly precise oligo(ethanamino)amides were synthesized comprising poly(ethylene glycol) conjugated MTX ligands. The conjugates differed in the number of additional glutamic acid residues to investigate the effect of different degrees of synthetic "a priori" polyglutamylation. The bioactivity of these compounds concerning dihydrofolate reductase (DHFR) inhibition, cytotoxicity, nucleic acid binding potency, cellular uptake of poly(I:C) polyplexes, and combined antifolate/poly(I:C) toxicity was investigated. Synthetic polyglutamylation had a crucial impact on several stages of efficient poly(I:C) delivery and combined MTX cytotoxicity. DHFR inhibition of the conjugates significantly increased with increasing polyglutamate chain length. The library member with highest glutamylation degree even outperformed free MTX in direct comparison. Studies in KB cells showed the corresponding enhanced cytotoxicity by polyglutamylation. Also poly(I:C) polyplexes of the glutamylated MTX variants exhibited higher cellular uptake in the folate receptor positive cell line. Finally, a synergistic combined cytotoxicity of polyglutamylated MTX ligands and complexed poly(I:C) cargo was observed in transfected KB cells. The present structure-activity relationship study of MTX-based ligands pinpoints the concept of synthetic polyglutamylation as a promising approach for optimizing bioactivity of antifolate conjugates, which might be considered as a useful tool also in context of other drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24754871     DOI: 10.1021/mp500017u

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Geared Toward Applications: A Perspective on Functional Sequence-Controlled Polymers.

Authors:  Cangjie Yang; Kevin B Wu; Yu Deng; Jingsong Yuan; Jia Niu
Journal:  ACS Macro Lett       Date:  2021-01-20       Impact factor: 6.903

2.  Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.

Authors:  Jianqin Lu; Wenchen Zhao; Yixian Huang; Hao Liu; Rebecca Marquez; Robert B Gibbs; Jiang Li; Raman Venkataramanan; Liang Xu; Shulin Li; Song Li
Journal:  Mol Pharm       Date:  2014-09-29       Impact factor: 4.939

3.  Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.

Authors:  Jiajiang Xie; Zhongxiong Fan; Yang Li; Yinying Zhang; Fei Yu; Guanghao Su; Liya Xie; Zhenqing Hou
Journal:  Int J Nanomedicine       Date:  2018-03-09

4.  Combined antitumoral effects of pretubulysin and methotrexate.

Authors:  Sarah Kern; Ines Truebenbach; Miriam Höhn; Jan Gorges; Uli Kazmaier; Stefan Zahler; Angelika M Vollmar; Ernst Wagner
Journal:  Pharmacol Res Perspect       Date:  2019-01-22

Review 5.  Directing the Way-Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery.

Authors:  Ricarda Carolin Steffens; Ernst Wagner
Journal:  Pharm Res       Date:  2022-09-15       Impact factor: 4.580

6.  DNA as Tunable Adaptor for siRNA Polyplex Stabilization and Functionalization.

Authors:  Philipp Heissig; Philipp M Klein; Philipp Hadwiger; Ernst Wagner
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-01       Impact factor: 10.183

Review 7.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.